SynthesisSleep & breathing = Schlaf & Atmung2025
Suicidality in adults with obstructive sleep apnea: A systematic review and Meta-Analysis.
Synthesis in Sleep & breathing = Schlaf & Atmung, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
purposeTo assess relations between obstructive sleep apnea (OSA) and suicidality, measured by suicidal ideation, suicide attempts, and death by suicide.
methodsCINAHL, Cochrane Library, PubMed, PsycINFO and SCOPUS were searched from inception through June 24, 2024. Observational studies related to suicidality in adult OSA patients were included. Case reports and studies on central sleep apnea were excluded. Data were extracted and reviewed by two authors, with disagreements resolved by a third. Risk of bias was assessed with the Risk Of Bias In Non-randomized Studies - of Exposure for cohort studies and the Joanna Briggs Institute checklist for case-control and cross-sectional studies. Random effects meta-analyses (single means, proportions, and relative risks (RR)) were performed.
resultsFifteen studies (n = 1,438,523) were included: eight assessed suicidal ideation, two assessed suicide attempts, and six assessed death by suicide. The OSA group experienced a higher prevalence of suicidal ideation (12.4% [95% CI: 8.9%-16.3%] vs. 3.7% [95% CI: 1.9%-6.2%]), suicide attempts (1.5% [95% CI: 0.9%-2.2%] vs. 0.9% [95% CI: 0.1%-2.2%]), and death by suicide (0.3% [95% CI: 0.2%-0.4%] vs. 0.2% [95% CI: 0.1%-0.3%]) than controls (p < 0.001). The OSA group had a higher risk of suicidal ideation (RR = 1.8, 95% CI: 1.5-2.1) and death by suicide (RR = 1.9, 95% CI: 1.1-3.4) than the control group (p < 0.001).
conclusionSuicidal ideation affects nearly 12% of patients with OSA, with close to 2% attempting suicide. Otolaryngologists should consider the risk of suicidality in these patients.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.